Balsam, P.; Lodziński, P.; Gawałko, M.; Kraj, L.; Śliwczyński, A.; Maciejewski, C.; Krzowski, B.; Tymińska, A.; Ozierański, K.; Grabowski, M.;
et al. Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial. J. Clin. Med. 2021, 10, 1780.
https://doi.org/10.3390/jcm10081780
AMA Style
Balsam P, Lodziński P, Gawałko M, Kraj L, Śliwczyński A, Maciejewski C, Krzowski B, Tymińska A, Ozierański K, Grabowski M,
et al. Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial. Journal of Clinical Medicine. 2021; 10(8):1780.
https://doi.org/10.3390/jcm10081780
Chicago/Turabian Style
Balsam, Paweł, Piotr Lodziński, Monika Gawałko, Leszek Kraj, Andrzej Śliwczyński, Cezary Maciejewski, Bartosz Krzowski, Agata Tymińska, Krzysztof Ozierański, Marcin Grabowski,
and et al. 2021. "Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial" Journal of Clinical Medicine 10, no. 8: 1780.
https://doi.org/10.3390/jcm10081780
APA Style
Balsam, P., Lodziński, P., Gawałko, M., Kraj, L., Śliwczyński, A., Maciejewski, C., Krzowski, B., Tymińska, A., Ozierański, K., Grabowski, M., Bednarski, J., & Opolski, G.
(2021). Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial. Journal of Clinical Medicine, 10(8), 1780.
https://doi.org/10.3390/jcm10081780